ABSTRACT
Aeromonas spp. are gram-negative aquatic bacteria involved in infections such as pneumonia, sepsis, hemolytic uremic syndrome, septic arthritis, and more recently they have been reported causing intestinal infections 1 .
Aeromonas diagnosis in most clinical laboratories, especially in developing countries, is based on phenotypic methods. The oxidase test is used for differential diagnosis from Enterobacteriaceae and a series of other biochemical tests are used for differential diagnosis from Vibrio and Plesiomonas 2 . The results are imprecise and Aeromonas is often misclassifi ed, being mainly misidentifi ed as Vibrio, which similarly grows on thiosulfate citrate bile salts sucrose (TCBS) and is oxidase positive 3 . Commercial systems for bacterial identification such as API20E and Vitek have proven useless for Aeromonas identifi cation 3, 4 . Hence, the role of Aeromonas as an etiologic agent of infection remains underestimated 2 .
Several molecular methods for genotypic identifi cation of Aeromonas spp.
5 are now available [6] [7] [8] [9] . However, most of them are species-specifi c and targeted to potential virulence genes. Hence, they are unable to recognize non-virulent Aeromonas species.
Here we describe a duplex polymerase chain reaction (PCR) that provided timely and accurate identifi cation of medically important Aeromonas spp. by amplifi cation of genes encoding glycerolphospholipid: cholesterol acyltransferase (gcat) and small subunit (16S) recombinant DNA (rRNA).
Preliminary Bacterial cultures were provided by the Bacterial Culture Collection of Health Importance/IOC/FIOCRUZ. Aeromonas strains were identifi ed genotypically by restriction fragment length polymorphism (RFLP) 6 and Vibrio isolates were typed by biochemical and serological methods. Extraction of chromosomal DNA from the cultures was performed as previously described 10 . Some authors 11, 12 have suggested that all Aeromonas spp. harbor gcat, but others report that some do not 7, 13, 14 . Therefore, we included the second primer targeted to the 16S gene. Primer sequences gcat-f: 5'-ctcctggaatcccaagtatcag-3' and 5'-gcat-r ggcaggttgaacagcagtatct-3' were previously described 15 , and 16S-f 5'-acgcaggcggttggataagt-3' and 5'-16S-r ggcaacaaaggacaggggt-3' were designed for the present study. For primer design, Aeromonas spp. 16S gene sequences were collected from the European Molecular Biology Laboratory (EMBL) database (accession nos. X60411, X60412, X60415, X60416, FJ998417, HM007582, AB034760, AJ224309, and FJ998415) and aligned by MegAlign (DNAstar), and the conserved regions within the gene were selected.
Duplex-PCR reactions were prepared in a total volume of 25µL containing 50mM KCl, 10mM Tris-HCl, 2.5M MgCl 2 , 400mM of each dNTP, 40pmol GCAT primers, 20pmol 16S primers, 1U Taq DNA polymerase (Promega), and 20ng DNA.
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The amplifications were performed in a Biometra T-3000 Genetic Analyzer thermal cycler programmed for 35 cycles of 1 min at 94°C, 1 min at 54°C, 1 min at 72°C and a fi nal 5 min extension at 72°C. Ten microliters of PCR products were electrophoresed in a 1% agarose gel containing SYBR Safe DNA gel stain (Invitrogen) at 100V for 1h, visualized on an ultraviolet (UV) transilluminator, and photographed using the Kodak 1D image analysis version 3.5 (Digital Kodak Science).
Duplex , and differential diagnosis is clinically challenging. These clinically important species were among those included in the present study.
The 2 target segments of gcat (237 bp) and 16S (~ 600 bp) were amplifi ed in all Aeromonas reference strains tested (Figure 1) (Figure 2, lanes 1-8) as well as in the 40 clinical isolates mentioned (data not shown). The gcat gene was not amplifi ed in any Vibrio species tested (Figure 2, lanes 9-16) . However, faint bands corresponding to 16S were seen with V. cholerae non-O1/ non-O139, V. alginolyticus, V. mimicus, and V. parahaemolyticus (Figure 2, lanes 10, 11, 14, and 15, respectively) .
Vibrio spp. were included because of their biochemical and serological similarities to Aeromonas, which, as noted, have previously made differentiation diffi cult. Although the 16S gene was amplifi ed in some of the Vibrio species, it did not hinder the effi cacy of the test, which recorded samples positive for Aeromonas only when both of the targeted genes were amplifi ed.
The duplex-PCR method introduced here showed high reproducibility and specifi city for Aeromonas spp. Therefore it should be useful as an alternative to phenotypic methods for identifying these bacteria and allowing a presumptive differentiation between the Aeromonadaceae and the Vibrionaceae that are commonly involved in human infections.
Rigorous validation of the technique should be sought by increasing testing with clinical Aeromonas isolates and other gram-negative oxidase positive bacteria strains. However, we consider publication of these preliminary results necessary because they indicate that laboratory identifi cation of Aeromonas spp. can be improved with the duplex-PCR method we describe.
If validated, this duplex-PCR method can be employed to more effectively evaluate the incidence of Aeromonas in human enteric disease during routine diagnosis versus the traditional phenotypic procedures. It will allow a better understanding of the emerging role Aeromonas species in the pathogenesis of enteric infections and assist in guiding appropriate control measures.
